Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
Irina Kareva(Northeastern University), Giannoula Klement(General Electric (Spain))
Cited by 254
Related Papers
Identifying key questions in the ecology and evolution of cancer
|Evolutionary Applications|2020|98
Predator-Prey in Tumor-Immune Interactions: A Wrong Model or Just an Incomplete One?
|Frontiers in Immunology|2021|50